glp-1 drugs compounding pharmacy FDA says that the shortage is over Compounded GLP-1 Treatment

Can they improve heart health

Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes

Online products marketed as research only do not provide the same protections

Same with Zepbound

Right upper abdominal pain particularly after meals suggests possible gallbladder problems

Combining weight loss medications increases the risk of side effects and is absolutely not suitable for everyone